These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4235807)

  • 1. Inhibition by quercetin of magnesium-, sodium- and potassium-activated adenosine triphosphatase.
    Bruni A; Carpenedo F; Santi R
    Br J Pharmacol; 1968 Nov; 34(3):673P-674P. PubMed ID: 4235807
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of sodium-potassium-activated adenosine triphosphatase by K+-Mg++-aspartate.
    Fedelesova M; Dzurba A; Ziegelhoffer A
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():155-9. PubMed ID: 4283209
    [No Abstract]   [Full Text] [Related]  

  • 3. The separation of sodium and potassium-activated adenosine-triphosphatase from a sodium or potassium inhibited adenosine-triphosphatase of cardiac muscle.
    Potter HA; Charnock JS; Opit LJ
    Aust J Exp Biol Med Sci; 1966 Oct; 44(5):503-18. PubMed ID: 4226250
    [No Abstract]   [Full Text] [Related]  

  • 4. The separation of sodium and potassium-activated adenosine-triphosphatase from a sodium or potassium inhibited adenosine-triphosphatase of cardiac muscle.
    Potter HA; Charnock JS; Opit LJ
    Aust J Exp Biol Med Sci; 1966 Oct; 44(5):503-17. PubMed ID: 4226249
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of oligomycin inhibition of sodium- and potassium-activated adenosine triphosphatase from beef brain.
    Inturrisi CE; Titus E
    Mol Pharmacol; 1968 Nov; 4(6):591-9. PubMed ID: 4235717
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of cardiac sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation.
    Akera T; Larsen FS; Brody TM
    J Pharmacol Exp Ther; 1970 May; 173(1):145-51. PubMed ID: 4245610
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of ouabain on sodium- and potassium-activated adenosine triphosphatase from the hearts of several mammalian species.
    Akera T; Larsen FS; Brody TM
    J Pharmacol Exp Ther; 1969 Nov; 170(1):17-26. PubMed ID: 4242640
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. II. Effects of sodium-activated transphosphorylation.
    Banerjee SP; Wong SM; Sen AK
    Mol Pharmacol; 1972 Jan; 8(1):18-29. PubMed ID: 4258646
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.
    Albers RW; Koval GJ; Siegel
    Mol Pharmacol; 1968 Jul; 4(4):324-36. PubMed ID: 4232893
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of brain sodium- and potassium-stimulated adenosine triphosphatase activity by chlorpromazine free radical.
    Akera T; Brody TM
    Mol Pharmacol; 1968 Nov; 4(6):600-12. PubMed ID: 4235718
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. I. Effects on sodium-sensitive phosphorylation and potassium-sensitive dephosphorylation.
    Banerjee SP; Wong SM; Khanna VK; Sen AK
    Mol Pharmacol; 1972 Jan; 8(1):8-17. PubMed ID: 4258649
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics.
    Palatini P
    Mol Pharmacol; 1977 Mar; 13(2):216-23. PubMed ID: 192990
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction between chlorpromazine free radical and microsomal sodium- and potassium-activated adenosine triphosphatase from rat brain.
    Akera T; Brody TM
    Mol Pharmacol; 1969 Nov; 5(6):605-14. PubMed ID: 4244695
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac sodium, potassium-adenosine triphosphatase as a possible site of adriamycin-induced cardiotoxicity.
    Solomonson LP; Halabrin PR
    Cancer Res; 1981 Feb; 41(2):570-2. PubMed ID: 6256069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of cardiac Na+, K+-adenosine triphosphatase in the mechanism of action of cardiac glycosides.
    Schwartz A; Allen JC; Harigaya S
    J Pharmacol Exp Ther; 1969 Jul; 168(1):31-41. PubMed ID: 4240030
    [No Abstract]   [Full Text] [Related]  

  • 16. Tritiated digoxin binding to (Na+ + K+)-activated adenosine triphosphatase: possible allosteric site.
    Schwartz A; Matsui H; Laughter AH
    Science; 1968 Apr; 160(3825):323-5. PubMed ID: 4230510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of tritiated ouabain to sodium- and potassium-activated adenosine triphosphatase and cardiac relaxing system of perfused dog heart.
    Allen JC; Besch HR; Glick G; Schwartz A
    Mol Pharmacol; 1970 Jul; 6(4):441-3. PubMed ID: 4246826
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of quercetin on membrane-linked activities.
    Carpenedo F; Bortignon C; Bruni A; Santi R
    Biochem Pharmacol; 1969 Jun; 18(6):1495-500. PubMed ID: 4307989
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
    [No Abstract]   [Full Text] [Related]  

  • 20. Membrane adenosine triphosphatase. The effect of potassium on the formation and dissociation of the ouabain-enzyme complex.
    Akera T; Brody TM
    J Pharmacol Exp Ther; 1971 Mar; 176(3):545-57. PubMed ID: 4255765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.